Gabriela Sacoto
- Omalizumab for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in children with cystic fibrosis (CF)By Silvia Gartner, Sandra Rovira, Inés de Mir, Alba Torrent, Belén Caurín, Gabriela Sacoto, Elisa Canino and Antonio Moreno-GaldóSilvia Gartner1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainSandra Rovira1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainInés de Mir1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainAlba Torrent1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainBelén Caurín1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainGabriela Sacoto1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainElisa Canino1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, SpainAntonio Moreno-Galdó1Pediatric Pulmonology and Cystic Fibrosis Unit, Hospital Universitay Valld´Hebron, Barcelona, Spain
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.